The results showed that AnxA6 protein was obviously reduced in HCC tissues with pathologic stage I-II and stage III compared to tissues of the pathologic stage I (p < 0.05) (Fig. 7D, Supplementary Fig. 5C). The gene discussed is ANXA6; the disease is hepatocellular carcinoma.